Cita APA (7a ed.)

Galstyan, K. O., Nedosugova, L. V., Petunina, N. A., Trakhtenberg, J. A., Vostokova, N. V., Karavaeva, O. V., & Chasovskaya, T. E. (2016). First Russian DPP-4 inhibitor Gosogliptin comparing to Vildagliptin in type 2 diabetes mellitus patients. Endocrinology Research Centre.

Cita Chicago Style (17a ed.)

Galstyan, Karina Oganesovna, Liudmila Viktorovna Nedosugova, Nina Alexandrovna Petunina, Julia Alexandrovna Trakhtenberg, Natalia Vadimovna Vostokova, Oksana Vladimirovna Karavaeva, y Tatiana Evgenievna Chasovskaya. First Russian DPP-4 Inhibitor Gosogliptin Comparing to Vildagliptin in Type 2 Diabetes Mellitus Patients. Endocrinology Research Centre, 2016.

Cita MLA (8a ed.)

Galstyan, Karina Oganesovna, et al. First Russian DPP-4 Inhibitor Gosogliptin Comparing to Vildagliptin in Type 2 Diabetes Mellitus Patients. Endocrinology Research Centre, 2016.

Precaución: Estas citas no son 100% exactas.